Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 10(1): 21423, 2020 12 08.
Artículo en Inglés | MEDLINE | ID: mdl-33293633

RESUMEN

Investigations of plasma amino acids in early psychosis and their unaffected siblings are rare. We measured plasma amino acids involved in the co-activation of dopaminergic, GABAergic, glutamatergic, and serotoninergic neurotransmitters in first-episode psychosis (FEP) patients (n = 166), unaffected siblings (n = 76), and community-based controls (n = 166) included in a cross-sectional study. Plasma levels of glutamic acid (GLU), glutamine, glycine, proline (PRO), tryptophan (TRP), tyrosine, serine and GABA were quantified by gas-chromatography-mass spectrometry. We used the generalized linear model adjusted by sex, age, and body mass index for group comparison and paired t-test for FEP-Sibling pairs. FEP had reduced GABA plasma levels compared to siblings and controls (p < 0.05 for both). Siblings had lower GLU, Glx and PRO (p < 0.05 for all) but increased TRP compared to patients and controls (p < 0.05 for both). FEP patients with longer duration of pharmacological treatment and medicated only with antipsychotics had increased GLU compared to FEP with shorter periods, or with those treated with a combination of medications (p < 0.05 for both). Finally, FEP patients treated only with antipsychotics presented higher Glx compared to those with mixed medications (p = 0.026). Our study suggests that FEP have low a GABA plasma profile. Unaffected siblings may be a possible risk group for metabolic abnormalities.


Asunto(s)
Aminoácidos/sangre , Antipsicóticos/uso terapéutico , Trastornos Psicóticos/sangre , Trastornos Psicóticos/tratamiento farmacológico , Hermanos , Adulto , Índice de Masa Corporal , Estudios de Casos y Controles , Estudios Transversales , Femenino , Cromatografía de Gases y Espectrometría de Masas , Ácido Glutámico/sangre , Glutamina/sangre , Glicina/sangre , Humanos , Modelos Lineales , Masculino , Prolina/análisis , Triptófano/sangre , Adulto Joven , Ácido gamma-Aminobutírico/sangre
2.
Mar Drugs ; 13(4): 1864-81, 2015 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-25837985

RESUMEN

This study aimed to examine the benefits of different amounts of omega-3 (n-3) polyunsaturated fatty acids from fish oil (FO) on lipid metabolism, insulin resistance and gene expression in rats fed a high-fructose diet. Male Wistar rats were separated into two groups: Control (C, n = 6) and Fructose (Fr, n = 32), the latter receiving a diet containing 63% by weight fructose for 60 days. After this period, 24 animals from Fr group were allocated to three groups: FrFO2 (n = 8) receiving 63% fructose and 2% FO plus 5% soybean oil; FrFO5 (n = 8) receiving 63% fructose and 5% FO plus 2% soybean oil; and FrFO7 (n = 8) receiving 63% fructose and 7% FO. Animals were fed these diets for 30 days. Fructose led to an increase in liver weight, hepatic and serum triacylglycerol, serum alanine aminotransferase and HOMA1-IR index. These alterations were reversed by 5% and 7% FO. FO had a dose-dependent effect on expression of genes related to hepatic ß-oxidation (increased) and hepatic lipogenesis (decreased). The group receiving the highest FO amount had increased markers of oxidative stress. It is concluded that n-3 fatty acids may be able to reverse the adverse metabolic effects induced by a high fructose diet.


Asunto(s)
Modelos Animales de Enfermedad , Ácidos Docosahexaenoicos/uso terapéutico , Ácido Eicosapentaenoico/uso terapéutico , Resistencia a la Insulina , Hígado/metabolismo , Síndrome Metabólico/dietoterapia , Triglicéridos/metabolismo , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Carbohidratos de la Dieta/efectos adversos , Suplementos Dietéticos/efectos adversos , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/efectos adversos , Ácido Eicosapentaenoico/administración & dosificación , Ácido Eicosapentaenoico/efectos adversos , Aceites de Pescado/administración & dosificación , Aceites de Pescado/efectos adversos , Aceites de Pescado/uso terapéutico , Fructosa/efectos adversos , Regulación Enzimológica de la Expresión Génica , Peroxidación de Lípido , Hígado/patología , Hígado/fisiopatología , Masculino , Síndrome Metabólico/metabolismo , Síndrome Metabólico/patología , Síndrome Metabólico/fisiopatología , Tamaño de los Órganos , Estrés Oxidativo , Distribución Aleatoria , Ratas Wistar , Triglicéridos/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...